FROVATRIPTAN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C14H17N3O
Molecular Weight	243.3043
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of FROVATRIPTAN

Structure Search

SMILES

CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(N)=O

InChI

InChIKey=XPSQPHWEGNHMSK-SECBINFHSA-N

InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C14H17N3O
Molecular Weight	243.3043
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:59:27 UTC 2023` Edited by `admin` on `Fri Dec 15 15:59:27 UTC 2023`
Record UNII	H82Q2D5WA7
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FROVATRIPTAN

Official Name

English

FROVATRIPTAN [HSDB]

Common Name

English

FROVATRIPTAN [VANDF]

Common Name

English

FROVATRIPTAN [MI]

Common Name

English

FROVATRIPTAN [MART.]

Common Name

English

frovatriptan [INN]

Common Name

English

Frovatriptan [WHO-DD]

Common Name

English

(R)-5,6,7,8-TETRAHYDRO-6-(METHYLAMINO)CARBAZOLE-3-CARBOXAMIDE

Systematic Name

English

Classification Tree Code System Code

NDF-RT

N0000175763

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

WHO-ATC

N02CC07

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

NDF-RT

N0000175765

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

WHO-VATC

QN02CC07

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

NCI_THESAURUS

C47794

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

NDF-RT

N0000175764

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

LIVERTOX

443

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

Code System Code Type Description

MERCK INDEX

m5571

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

Merck Index

NCI_THESAURUS

C65772

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

SMS_ID

100000080448

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

FDA UNII

H82Q2D5WA7

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

LACTMED

Frovatriptan

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

IUPHAR

7191

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

DAILYMED

H82Q2D5WA7

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

HSDB

7363

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

RXCUI

228783

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

RxNorm

DRUG BANK

DB00998

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

EVMPD

SUB07817MIG

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

DRUG CENTRAL

1251

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

ChEMBL

CHEMBL1279

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

WIKIPEDIA

FROVATRIPTAN

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

INN

7661

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

PUBCHEM

77992

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

CAS

158747-02-5

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

EPA CompTox

DTXSID0023080

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

MESH

C108128

Created by admin on Fri Dec 15 15:59:27 UTC 2023 , Edited by admin on Fri Dec 15 15:59:27 UTC 2023

PRIMARY

Related Record Type Details


					D28J6W18HY

Frovatriptan Succinate

SALT/SOLVATE -> PARENT

Amount:


					ZI18M2JAY5

5-HYDROXYTRYPTAMINE RECEPTOR 1D

TARGET -> AGONIST

Qualification:

pKi

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					H82Q2D5WA7

EXCRETED UNCHANGED

Comments:

oral administration

Interaction Type:

AMOUNT EXCRETED

Qualification:

FECAL

Amount:


					VK4SQL11C0

CYTOCHROME P450 1A2

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					H82Q2D5WA7

EXCRETED UNCHANGED

Comments:

oral administration

Interaction Type:

AMOUNT EXCRETED

Qualification:

URINE

Amount:


					H82Q2D5WA7

EXCRETED UNCHANGED

Comments:

intravenous administration

Interaction Type:

AMOUNT EXCRETED

Qualification:

URINE

Amount:

Related Record Type Details


					L1BW3Q7DKQ

N-DEMETHYLFROVATRIPTAN

METABOLITE -> PARENT

Qualification:

URINE

Amount:


					8F3M97M8TF

(6R)-6-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H-CARBAZOLE-3-CARBOXYLIC ACID

METABOLITE -> PARENT

Interaction Type:

MAJOR

Qualification:

FECAL

Amount:


					FN5D606P9U

N-ACETYL DESMETHYL FROVATRIPTAN

METABOLITE -> PARENT

Qualification:

URINE

Amount:

Related Record Type Details


					H82Q2D5WA7

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Tmax	PHARMACOKINETIC				ORAL ADMINISTRATION

Biological Half-life	PHARMACOKINETIC